STEM CELL THERAPEUTICS Aktie

0,00 EUR 0,0000%

Zu Ihrem Onlinebroker

kaufen verkaufen

STEM CELL THERAPEUTICS Aktienkurs : 08:10 ( 15 Min. verzögert)
0,0010 € Letzter Kurs	0,00% Veränderung	0,0010 € Vortag	0,0010 € Eröffnungskurs

Realtime:

0,00

0,00%

mehr Informationen

Hoch/Tief		Volumen		Geldkurs	Briefkurs
0,0010 - 0,0010 Tag	0,0300 - 0,0010 52 Wochen	0 Tag	0 Ø 52 Wochen	0,0010 2.000.000 Stücke	0,0780 25.642 Stücke

STEM CELL THERAPEUTICS Aktien…

Wollen Sie wissen, wie es mit dieser Aktie weitergeht?
Wir informieren Sie kostenlos.

Erhalten Sie außerdem Expertenanalysen von:
Gevestor Täglich und John Gossens Daily DAX

21.05.

UTHealth Pediatric Surgery Expands Regenerative Medicine Program

At UTHealth, Triolo runs the Judith R. Hoffberger translational laboratory and the Evelyn H. Griffin Stem Cell Therapeutics Research Laboratory and his role is to “translate, scale-up and validate promising new therapeutic technologies developed by our ...
15.05.

Athersys-Pfizer IBD phase 2 trial to wrap up by end of the year

Stem cell therapeutics developer Athersys' (NASDAQ:ATHX) phase 2 clinical study investigating the treatment of inflammatory bowel disease with partner Pfizer (NYSE:PFE) is expected to complete pa…

09.05.

David Allan Lauded for Leadership – Biotechnology Leader Named to Industry Award

... I am delighted to continue broad involvement with the biotechnology industry in Canada as the Chair of YM, Executive Chair of Stem Cell Therapeutics Corp, Lead Director at DiaMedica Inc, and as Chairman of AvidBiologics Inc. in Toronto.
08.05.

Genomic Health Partners with OncoMed to Grow Companion Dx, NGS Reach

OncoMed is working on anti-cancer stem cell therapeutics targeting the Notch, Wnt, and RSPO-LGR pathways. It is developing some of these on its own and has partnered with...
08.05.

David Allan Lauded for Leadership – Biotechnology Leader Named to Industry Award

... I am delighted to continue broad involvement with the biotechnology industry in Canada as the Chair of YM, Executive Chair of Stem Cell Therapeutics Corp, Lead Director at DiaMedica Inc, and as Chairman of AvidBiologics Inc. in Toronto.